Table 5 Growth inhibition percentage (GI%) of compounds 12d and 12i on breast cancer (MDA-MB-468) and leukemia (CCRF-CM) cell lines under normoxic and hypoxic condition.

From: Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX

Compound

GI%

Normoxia

Hypoxia

MDA-MB-468

CCRF-CM

MDA-MB-468

CCRF-CM

12d

61.39

52.61

59.38

55.82

12i

16.58

0.76

64.75

50.14

Back to article page